Skip to main content
. Author manuscript; available in PMC: 2011 Sep 30.
Published in final edited form as: Oncogene. 2010 Nov 29;30(13):1566–1576. doi: 10.1038/onc.2010.532

Figure 5. α5β1-Integrin signals through c-Met to activate FAK and Src.

Figure 5

(a) HeyA8 cells were transfected with c-Met siRNA or with scrambled siRNA, plated on fibronectin and treated with human α5Ab. Cells were lysed, resolved on SDS-PAGE, transferred to nitrocellulose membrane and probed with the indicated antibodies. (b) HeyA8 cells were plated on fibronectin and treated with human α5Ab as indicated for 24 h. The cells were then treated with HGF/SF for 30 min and immunoblotting performed with the specified antibodies. Results in (a) and (b) are representative of three independent experiments. (c) SKOV3ip1 xenografts were treated with human α5Ab or with IgG as described in Figure 1 (b) Left: Tumor lysates were immunoblotted with the indicated antibodies. Right: Representative image of tumor sections stained for p-FAK-Y397 (x200). Images of sections from 5 mice were quantified using Image J (*p<0.001). (d) Immunoprecipitation. HeyA8 cells were plated on fibronectin and treated with human α5Ab or control IgG for 24 h followed by immunoprecipitation with an antibody against c-Met or Src, respectively followed by immunoblotting (WB) Src and c-Met. All results are representative of at least three independent experiments.